PROGNOSTIC ROLE OF PATHOLOGICAL CHEMOTHERAPY RESPONSE SCORE IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR EPITHELIAL OVARIAN CANCER

被引：0
|
作者：
Setton, Ariella Jakobson [1 ,2 ]
Levin, Gabriel [3 ]
Raban, Oded [1 ,2 ]
Sabah, Gad [1 ,2 ]
Tsoref, Daliah [4 ]
From, Anat [1 ,5 ]
Perri, Tamar [3 ]
Eitan, Ram [5 ]
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Obstet & Gynecol, Tel Aviv, Israel
[3] Hadassah Univ Hosp, Obstet & Gynecol, Jerusalem, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Dept Oncol, Rabin Med Ctr Petah Tikva, Tel Aviv, Israel
[5] Tel Aviv Univ, Dept Obstet & Gynecol, Sackler Fac Med, Tel Aviv, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2022年 / 32卷
关键词：
D O I：
10.1136/ijgc-2022-igcs.319
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP228/#913
引用
收藏
页码：A142 / A143
页数：2
相关论文
共 50 条
  • [21] Chemotherapy response score is a prognostic tool in advanced stage endometrial cancer patients treated with neoadjuvant chemotherapy
    Jani, Ina
    Lastra, Ricardo R.
    Brito, Katherine
    Liao, Chuanhong
    Lazo, Isabel Maria
    Kurnit, Katherine C.
    Lee, Nita K.
    Yamada, Seiko Diane
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : E26 - E26
  • [22] The clinical response of advanced epithelial ovarian cancer patients to neoadjuvant chemotherapy in China
    Yao, K.
    Bian, C.
    Li, L.
    Wu, Y.
    Zhao, X.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (03) : 377 - 380
  • [23] The role of neoadjuvant chemotherapy in patients with advanced (stage IIIC) epithelial ovarian cancer
    Skof, Erik
    Merlo, Sebastjan
    Pilko, Gasper
    Kobal, Borut
    RADIOLOGY AND ONCOLOGY, 2016, 50 (03) : 341 - 346
  • [24] THE ROLE OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH ADVANCED (STAGE IIIC) EPITHELIAL OVARIAN CANCER
    Skof, E.
    Cerar, O.
    Bebar, S.
    Djurisic, A.
    Merlo, S.
    Vakselj, A.
    Kobal, B.
    Cvjeticanin, B.
    Barbic, M.
    Meglic, L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 1494 - 1494
  • [25] The predictors of response to neoadjuvant chemotherapy in advanced epithelial ovarian cancer
    Yildirim, Yusuf
    Ertas, Ibrahim Egemen
    Dogan, Askin
    Gultekin, Ozge Elmastas
    Gultekin, Emre
    JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (02) : 200 - 205
  • [26] The Role of Neoadjuvant Chemotherapy in Treating Advanced Epithelial Ovarian Cancer
    Weinberg, Lori E.
    Rodriguez, Gustavo
    Hurteau, Jean A.
    JOURNAL OF SURGICAL ONCOLOGY, 2010, 101 (04) : 334 - 343
  • [27] VENOUS THROMBOEMBOLISM IN PATIENTS RECEIVING NEOADJUVANT CHEMOTHERAPY FOR OVARIAN CANCER
    Black, K.
    Ghosh, S.
    Singh, N.
    Chu, P.
    Pin, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 : A133 - A133
  • [28] Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy
    Weissferdt, Annikka
    Pataer, Apar
    Vaporciyan, Ara A.
    Correa, Arlene M.
    Sepesi, Boris
    Moran, Cesar A.
    Wistuba, Ignacio I.
    Roth, Jack A.
    Shewale, Jitesh Baban
    Heymach, John, V
    Kalhor, Neda
    Cascone, Tina
    Hofstetter, Wayne L.
    Lee, J. Jack
    Swisher, Stephen G.
    CLINICAL LUNG CANCER, 2020, 21 (04) : 341 - 348
  • [29] Incidence of venous thromboembolism among patients receiving neoadjuvant chemotherapy for advanced epithelial ovarian cancer
    Salinaro, Julia Rose
    McQuillen, Kourtnie
    Stemple, Megan
    Boccaccio, Robert
    Ehrisman, Jessie
    Lorenzo, Amelia M.
    Havrilesky, Laura
    Secord, Angeles Alvarez
    Galvan Turner, Valerie
    Moore, Kathleen Nadine
    Davidson, Brittany
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2020, 30 (04) : 491 - 497
  • [30] Prognostic significance of pretreatment clinical and laboratory features in patients with ovarian cancer receiving neoadjuvant chemotherapy
    Sekmek, Serhat
    Bayram, Dogan
    Efil, Safa Can
    Ucar, Gokhan
    Sendur, Mehmet Ali Nahit
    Kos, Fahriye Tugba
    ONCOLOGY IN CLINICAL PRACTICE, 2024,
12345